We are live on ! Find out more
GALT icon

Galectin Therapeutics

60 hedge funds and large institutions have $9.26M invested in Galectin Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more call options, than puts

Call options by funds: $185K | Put options by funds: $173K

0% more funds holding

Funds holding: 6060 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.69% less ownership

Funds ownership: 12.58%11.89% (-0.69%)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

23% less capital invested

Capital invested by funds: $12M → $9.26M (-$2.76M)

Holders
60
Holders Change
Holders Change %
0%
% of All Funds
1.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
11
Reduced
14
Closed
5
Calls
$185K
Puts
$173K
Net Calls
+$12K
Net Calls Change
-$163K